Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (CCC1C(COC1=O)CC2=CN=CN2C 1) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: The second molecule (C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C6CCCC6)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C 1) contains a nitro group (-NO2), which is known to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: The third molecule (CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to cardiovascular disorders.
3. Rule 3: If a molecule contains a functional group such as a sulfonamide group, it is more likely to cause adverse effects related to gastrointestinal disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a phenyl group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C 1) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: The second molecule (C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N 1) contains a nitro group (-NO2), which is known to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: The third molecule (C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)O)N 0) contains a halogen atom (-Cl), which is known to cause adverse effects related to skin and eye disorders.
The fourth molecule (CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C 0) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to musculoskeletal and connective tissue disorders.
The fifth molecule (C1N2CN3CN1CN(C2)C3.C1=CC=C(C=C1)C(=O)NCC(=O)O 0) contains a nitro group (-NO2), which is known to cause adverse effects related to respiratory and cardiovascular disorders.
The sixth molecule (CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl 0) contains a halogen atom (-Cl), which is known to cause adverse effects related to skin and eye disorders.
The seventh

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a sulfonamide group (-SO2NH2), it is likely to cause adverse effects related to gastrointestinal disorders.
3. Rule 3: If the molecule contains a piperazine ring (-C4H8N2), it is likely to cause adverse effects related to central nervous system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule containing a carboxylic acid group (-COOH) is listed under label 1, which means it is related to the side-effect activity of a molecule related to musculoskeletal and connective tissue disorders.
2. Rule 2: The molecule containing a sulfonamide group (-SO2NH2) is listed under label 1, which means it is related to the side-effect activity of a molecule related to musculoskeletal and connective tissue disorders.
3. Rule 3: The molecule containing a piperazine ring (-C4H8N2) is listed under label 1, which means it is related to the side-effect activity of a molecule related to musculoskeletal and connective tissue disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to reproductive disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N 1 contains a carboxylic acid group (-COOH) and is labeled as 1, which means it is related to the side-effect activity of a molecule related to musculoskeletal and connective tissue disorders.
2. Rule 2: The molecule CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O 1 contains a benzene ring (C6H5) and is labeled as 1, which means it is related to the side-effect activity of a molecule related to respiratory disorders.
3. Rule 3: The molecule CC1=C2C(=C(C(=C1C)OC(=O)CCC(=O)OCCO)C)CCC(O2)(C)CCCC(C)CCCC(C)C 0 contains a nitro group (-NO2) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to reproductive disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

1. Rule 1: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If a molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to neurological disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to neurological disorders.
3. Rule 3: If the molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to respiratory disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: The second molecule (CCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C) contains a benzene ring (C6H5), which is known to cause adverse effects related to neurological disorders.
3. Rule 3: The third molecule (CC1(C(NC(S1)C(C(=O)NCCCCCC(=O)O)NC(=O)CC2=CC=CC=C2)C(=O)O)C) contains a chlorine atom (Cl), which is known to cause adverse effects related to respiratory disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a functional group such as a sulfonamide, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

1. Rule 1: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Explanation:
1. The first rule is based on the observation that carboxylic acid groups (-COOH) are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. Carboxylic acids are known to interact with collagen, a protein found in tendons and ligaments, which can lead to tissue damage and inflammation.
2. The second rule is based on the observation that halogenated aromatic rings are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. Halogenated aromatic rings can interact with proteins and enzymes in the body, which can lead to tissue damage and inflammation.
3. The third rule is based on the observation that nitro groups (-NO2) are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. Nitro groups can react with proteins and enzymes in the body, which can lead to tissue damage and inflammation.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
These rules are based on the fact that carboxylic acid groups, halogenated aromatic rings, and nitro groups are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. However, it is important to note that these rules are not foolproof and there may be exceptions to each rule. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O, contains a carboxylic acid group (-COOH). It is labeled as 0, which means it is not related to the side-effect activity of a molecule related to musculoskeletal and connective tissue disorders. Therefore, this molecule is not likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: The second molecule, CC[C@@H]1[C@@]2([C@@H]([C@@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C, contains a nitro group (-NO2). It is labeled as 1, which means it is related to the side-effect activity of a molecule related to respiratory and cardiovascular disorders. Therefore, this molecule is likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: The third molecule, CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If a molecule contains a nitrogen atom, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye disorders.
These rules are based on the observation that the molecules that contain these functional groups are more likely to cause adverse effects than those that do not. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the adverse effects of a molecule.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye disorders.
These rules can be inferred by analyzing the labels assigned to the smiles strings in the provided data. For example, the first rule can be inferred by analyzing the label 1 assigned to the smiles string "CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N", which indicates that the molecule contains a carboxylic acid group and is related to adverse effects related to musculoskeletal and connective tissue disorders. Similarly, the second and third rules can be inferred by analyzing the labels assigned to the smiles strings in the provided data.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Explanation:
1. The first rule is based on the fact that carboxylic acid groups are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. For example, diclofenac, a non-steroidal anti-inflammatory drug (NSAID), contains a carboxylic acid group and is known to cause adverse effects such as stomach ulcers, bleeding, and kidney damage.
2. The second rule is based on the fact that halogenated aromatic rings are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. For example, flurbiprofen, a NSAID, contains a halogenated aromatic ring and is known to cause adverse effects such as stomach ulcers, bleeding, and kidney damage.
3. The third rule is based on the fact that nitro groups are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. For example, nitroglycerin, a vasodilator, contains a nitro group and is known to cause adverse effects such as chest pain, shortness of breath, and headache.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains both a carboxylic acid group (-COOH) and a chlorine atom (Cl), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule (C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl 1) contains a carboxylic acid group (-COOH) and is labeled as causing adverse effects related to musculoskeletal and connective tissue disorders (label 1).
2. Rule 2: The second molecule (CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl 1) contains a chlorine atom (Cl) and is labeled as not causing adverse effects related to musculoskeletal and connective tissue disorders (label 0).
3. Rule 3: The third molecule (CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F 1) contains both a carboxylic acid group (-COOH) and a chlorine atom (Cl) and is labeled as causing adverse effects related to musculoskeletal and connective tissue disorders (label 1).

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If a molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group, it is less likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is less likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Explanation:
1. Rule 1 is based on the fact that carboxylic acid groups are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. For example, diclofenac, a non-steroidal anti-inflammatory drug (NSAID), contains a carboxylic acid group and is known to cause adverse effects such as stomach ulcers and bleeding. Similarly, molecules that contain carboxylic acid groups such as aspirin, ibuprofen, and naproxen are also known to cause adverse effects.
2. Rule 2 is based on the fact that nitro groups are commonly found in molecules that are safe for use in humans. Nitro groups are found in molecules such as acetaminophen, which is commonly used as a pain reliever and fever reducer. Acetaminophen does not contain a carboxylic acid group and is considered safe for use in humans.
3. Rule 3 is based on the fact that halogenated aromatic rings are commonly found in molecules that are safe for use in humans. Halogenated aromatic rings are found in molecules such as acetaminophen, which is commonly used as a pain reliever and fever reducer. Acetaminophen does not contain a carboxylic acid group and is considered safe for use in humans.

================================

1. Rule 1: If a molecule contains a nitrogen atom, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If a molecule contains a halogen atom, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If a molecule contains a carbonyl group, it is more likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye disorders.
These rules can be inferred by analyzing the labels and structures of the molecules provided in the data. For example, the first molecule contains a carboxylic acid group, which is known to cause adverse effects related to musculoskeletal and connective tissue disorders. Similarly, the second molecule contains a nitro group, which is known to cause adverse effects related to respiratory and cardiovascular disorders. The third molecule contains a halogen atom, which is known to cause adverse effects related to skin and eye disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to neurological disorders.
These rules are based on the observation that molecules with these functional groups are commonly associated with adverse effects in humans. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a tertiary amine group (-N(CH3)3), it is likely to cause adverse effects related to cardiovascular disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
These rules are based on the fact that each of these functional groups is associated with a specific type of adverse effect. However, it is important to note that these rules are not definitive and other factors such as dosage, route of administration, and individual susceptibility may also play a role in determining the potential adverse effects of a molecule.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to cardiovascular disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to neurological disorders.
Explanation:
1. Rule 1 is based on the observation that carboxylic acid groups are commonly found in molecules that cause adverse effects related to musculoskeletal and connective tissue disorders. Carboxylic acid groups are known to interact with collagen, a protein found in connective tissue, which can lead to tissue damage and inflammation.
2. Rule 2 is based on the observation that nitro groups are commonly found in molecules that cause adverse effects related to cardiovascular disorders. Nitro groups are known to interact with blood vessels and can cause constriction, which can lead to high blood pressure and other cardiovascular problems.
3. Rule 3 is based on the observation that halogenated aromatic rings are commonly found in molecules that cause adverse effects related to neurological disorders. Halogenated aromatic rings are known to interact with neurotransmitters in the brain, which can lead to changes in mood and behavior.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to respiratory disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.

================================

